Callan Family Office’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Buy
1,693
+357
+27% +$63K ﹤0.01% 1089
2026
Q1
$240K Sell
1,336
-268
-17% -$45.8K 0.01% 1000
2025
Q4
$227K Buy
+1,604
New +$182K ﹤0.01% 1017

Other funds holding ALB

Callan Family Office's ALB Position: Q2 2026 in Review

Callan Family Office increased its Albemarle (ALB) stake by 27% in Q2 2026, buying an estimated $63K and bringing the position to 1,693 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Callan Family Office first reported a position in ALB in Q4 2025 and has held it in 3 quarters since. The position peaked at $240K in Q1 2026. 945 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Callan Family Office held 1,693 shares of Albemarle worth $229K as of Q2 2026.
  • Callan Family Office bought 357 Albemarle shares in Q2 2026, an estimated $63K.
  • Albemarle made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1089 holding.
  • Callan Family Office first reported a position in Albemarle in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Albemarle position peaked at $240K in Q1 2026.
  • 945 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.